Oncoclínicas do Brasil Serviços Médicos S.A. (ONCO3.SA)
BRL 2.16
(-14.29%)
BRL 2.16
(-14.29%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 5.48 Billion | 4.08 Billion | 2.7 Billion | 2.03 Billion | 1.68 Billion | 1.05 Billion |
| Cost of Revenue | 3.56 Billion | 2.63 Billion | 1.83 Billion | 1.39 Billion | 1.22 Billion | 741.43 Million |
| Gross Profit | 1.92 Billion | 1.45 Billion | 868.79 Million | 635.67 Million | 460.52 Million | 309.4 Million |
| Operating Expenses | 1.17 Billion | 981 Million | 691.57 Million | 616.06 Million | 338.77 Million | 237.68 Million |
| Selling, General and Administrative Expenses | 1.17 Billion | 980.81 Million | 688.05 Million | 603.6 Million | 340.72 Million | 221.29 Million |
| Research and Development Expenses | - | - | - | - | - | 249 Thousand |
| Other Expenses | -1.51 Million | - | - | - | - | - |
| Cost and Expenses | 4.73 Billion | 3.61 Billion | 2.52 Billion | 2.01 Billion | 1.56 Billion | 979.11 Million |
| Operating Income | 758.01 Million | 470.56 Million | 177.21 Million | 19.61 Million | 121.75 Million | 82.74 Million |
| Interest Expense | 559.78 Million | 396.47 Million | 154.36 Million | 72.06 Million | 41.6 Million | 26.61 Million |
| Income Tax Expense | -10.04 Million | 7.77 Million | 84.75 Million | 68.08 Million | 61.27 Million | 37.51 Million |
| Earnings before Tax | 302.51 Million | 121.54 Million | 62.33 Million | -57.11 Million | 80.36 Million | 53.76 Million |
| Net Income | 223.61 Million | 46.26 Million | -46.9 Million | -159.61 Million | -20.41 Million | -17.07 Million |
| Earnings Per Share Basic | 0.43 | 0.10 | -0.10 | -39.41 | -5.10 | -0.05 |
| Earnings Per Share Diluted | 0.42 | 0.09 | -0.10 | -39.41 | -5.10 | -0.05 |
| Weighted Average Shares Outstanding | 523.65 Million | 479.83 Million | 474.78 Million | 4.05 Million | 4 Million | 359.09 Million |
| Weighted Average Shares Outstanding (Diluted) | 535.51 Million | 531.69 Million | 474.78 Million | 4.05 Million | 4 Million | 359.09 Million |
| Gross Margin | 0.35 | 0.36 | 0.32 | 0.31 | 0.27 | 0.29 |
| EBIT Margin | 0.21 | 0.17 | 0.13 | 0.06 | 0.11 | 0.09 |
| Profit Margin | 0.04 | 0.01 | -0.02 | -0.08 | -0.01 | -0.02 |
| EBITDA | 1.16 Billion | 730.36 Million | 337.07 Million | 126.42 Million | 196.1 Million | 95.97 Million |
| Earnings Before Tax Margin | 0.14 | 0.12 | 0.07 | 0.01 | 0.07 | 0.08 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 1.56 Billion | 1.45 Billion | 5.48 Billion | 1.43 Billion | 1.4 Billion | 1.35 Billion |
| Cost of Revenue | 1.04 Billion | 976.38 Million | 3.56 Billion | 947.48 Million | 905.76 Million | 884.03 Million |
| Gross Profit | 526.96 Million | 482.28 Million | 1.92 Billion | 486.76 Million | 495.78 Million | 475.48 Million |
| Operating Expenses | 311.12 Million | 316.96 Million | 1.17 Billion | 303.86 Million | 312.32 Million | 288.08 Million |
| Selling, General and Administrative Expenses | 311.12 Million | 316.96 Million | - | 303.86 Million | 308.74 Million | 288.22 Million |
| Research and Development Expenses | - | - | - | 37 Thousand | - | 2000.00 |
| Other Expenses | 2.42 Million | - | - | - | - | - |
| Cost and Expenses | 1.35 Billion | 1.29 Billion | 4.73 Billion | 1.25 Billion | 1.21 Billion | 1.17 Billion |
| Operating Income | 215.84 Million | 165.31 Million | 756.5 Million | 182.9 Million | 184.26 Million | 187.6 Million |
| Interest Expense | 143.88 Million | 156.95 Million | 559.78 Million | 140.73 Million | 137.69 Million | 138.81 Million |
| Income Tax Expense | 16.79 Million | -44.69 Million | -10.04 Million | 32.1 Million | -111.38 Million | 35.51 Million |
| Earnings before Tax | 40.82 Million | -25.1 Million | 314.16 Million | 123.5 Million | 37.94 Million | 70.48 Million |
| Net Income | 3.3 Million | 9.59 Million | 223.61 Million | 75.43 Million | 104.98 Million | 21 Million |
| Earnings Per Share Basic | 0.01 | 0.02 | - | 0.15 | 0.20 | 0.04 |
| Earnings Per Share Diluted | 0.01 | 0.02 | - | 0.14 | 0.20 | 0.04 |
| Weighted Average Shares Outstanding | 565.42 Million | 545.91 Million | 523.65 Million | 508.28 Million | 515.83 Million | 517.86 Million |
| Weighted Average Shares Outstanding (Diluted) | 581.24 Million | 561.73 Million | 535.51 Million | 542.32 Million | 526.99 Million | 528.25 Million |
| Gross Margin | 0.34 | 0.33 | 0.35 | 0.34 | 0.35 | 0.35 |
| EBIT Margin | 0.18 | 0.16 | - | 0.17 | 0.18 | 0.18 |
| Profit Margin | 0.00 | 0.01 | 0.04 | 0.05 | 0.07 | 0.02 |
| EBITDA | 285.58 Million | 232.96 Million | - | 248.77 Million | 252.79 Million | 249.01 Million |
| Earnings Before Tax Margin | 0.14 | 0.11 | 0.14 | 0.13 | 0.13 | 0.14 |
SXL
016740
SFL
7839
7609
COIN